Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients
NCT ID: NCT04739137
Last Updated: 2021-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2021-01-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Comparing Two Populations of Patients Treated With Anti VEGF for Diabetic Macular Edema, One Being Followed at the Hospital and the Other One Being Followed at Home Using a Software Allowing Self-assessment of Visual Acuity
NCT04776343
The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration
NCT07060196
The Evolution of Visual Acuity Measured by Electronic Tablet / Computer of Exudative AMD Patients
NCT03214484
Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration
NCT04084587
Development of a Validated Chart for Intermediate Vision Assessment
NCT02279446
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
100 patients with diagnosed macular edema will be enrolled
DDiVAT Testing
Participants will self examine his/her distance visual acuity via application in a simulation room of our department with certain predetermined environmental lighting conditions using the same smart devices.
Distance visual acuity assessment via ETDRS chart
The distance visual acuity of each participant will be measured with the conventional method via ETDRS chart
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DDiVAT Testing
Participants will self examine his/her distance visual acuity via application in a simulation room of our department with certain predetermined environmental lighting conditions using the same smart devices.
Distance visual acuity assessment via ETDRS chart
The distance visual acuity of each participant will be measured with the conventional method via ETDRS chart
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diabetic macular edema
Exclusion Criteria
* glaucoma
* psychiatric disorders
* inability to cooperate
40 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Democritus University of Thrace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Georgios Labiris
Professor (Associate) of Democritus University of Thrace
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Georgios Labiris
Role: STUDY_CHAIR
Democritus University of Thrace
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Democritus University of Thrace
Alexandroupoli, Evros, Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ES1/Th5/21-1-2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.